KA-1002, a Novel Lysophosphatidic Acid Signaling Antagonist, Alleviates Bovine Tracheal Cell Disruption and Inflammation
The industrial livestock environment can cause stress and weakened immunity in cattle, leading to microbial infections which reduce productivity. As such, there is a need for an effective therapeutic agent that can alleviate uncontrolled destructive respiratory inflammation. We found that lysophosph...
Main Authors: | Hee-su Shin, Miok Kim, Kwang Soo Kim, Yong Ki Min, Chang Hoon Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/10/2/295 |
Similar Items
-
A Novel Therapeutic Reagent, KA-1002 for Alleviating Lysophosphatidic Acid-Mediated Inflammation Related Gene Expression in Swine Macrophages
by: Hyeon-Jeong Hwang, et al.
Published: (2020-03-01) -
Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
by: Yu-Hsuan Lin, et al.
Published: (2021-06-01) -
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay
by: C. Ruzza, et al.
Published: (2023-11-01) -
Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases
by: Shufan Jiang, et al.
Published: (2023-08-01) -
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
by: Bicheng Yang, et al.
Published: (2017-11-01)